The contemporary management of heart failure is characterized by evolving strategies to combine newer approaches based on research advances with well established evidence-based standards of care. The University of North Carolina (UNC) Heart Failure Conference is designed to provide a comprehensive overview of the current strategies for the treatment of heart failure. Course faculty will review cutting-edge approaches to diagnosis and classification and provide techniques and tips for the pharmacological and device management of heart failure. The material presented will have an interdisciplinary focus and will be of interest to physicians and other health care professionals who care for patients with heart failure.
The information presented at this evidence-based activity should improve your ability to:
- Discuss the clinical profile of heart failure and differentiate types of heart failure based on state of patient’s left ventricular ejection fraction: reduced, preserved, or midrange
- Apply appropriate strategies to optimize pharmacologic treatment of heart failure with reduced and preserved left ventricular ejection fraction
- Evaluate patients for advanced surgical and interventional therapies for heart failure including left ventricular assist device, cardiac transplantation, and transcatheter mitral valve replacement
- Understand options for electrophysiological interventions and the use of biomarker assessment in the care of patients with heart failure
- Discuss future directions in the management of heart failure
This course is designed for Cardiologists, Family Medicine Physicians, General Internists, Nurses and Nurse Practitioners, Physician Assistants, Pharmacists, Hospitalists and Cardiology Technicians.
Course faculty will present information in a case discussion and lecture format. There will be opportunities for the audience to ask questions in a panel discussion setting.
University of Florida College of Medicine adheres to the ACCME Standards regarding commercial support of continuing medical education. It is policy that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this education activity, that relevant conflicts of interest are resolved, and that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the course syllabus.